Archive for July 2018
Onkos Surgical and Insight Medical Systems Team Up On an Augmented Reality Surgical System
Insight Medical Systems has teamed up with Onkos Surgical, Inc. to explore opportunities to apply Insight Medical’s ARVIS™ (Augmented Reality Visualization and Information System) in musculoskeletal oncology. The companies are working on a pilot project to assess the technology for use in tumor surgery. ARVIS™, currently under development, has tracking and visualization capabilities which allow precise and efficient…
Read MoreImaging Group MITA Warns China Tariffs Will Cost $138M to US Imaging Industry
The Medical Imaging and Technology Alliance (MITA) – the leading organization and collective voice of medical imaging equipment, radiopharmaceutical manufacturers, innovators, and product developers – today called on the Trump Administration to establish a timely and robust exemption process for medical imaging products and components from China Section 301 tariffs, which went into effect today.…
Read MoreAxonics Receives CE Mark for Sacral Neuromodulation External Trial System
Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and bowel dysfunction, announced today that it has received the CE mark for its Sacral Neuromodulation External Trial System. Axonics received CE mark in June 2016 for its miniaturized implantable neurostimulator, tined lead, programmers, charger and related accessories. The External Trial System…
Read MoreFDA Clearance for Embolx’s Next Gen Sniper Balloon Occlusion Microcatheter
Embolx, Inc., a medical device company developing microcatheters for arterial embolization procedures, today announced that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its next generation family of Sniper® Balloon Occlusion Microcatheters, an innovative system for pressure-directed arterial embolization therapy. Now commercially available in the United States,…
Read MoreBreath Biopsy Platform Wins UK’s Most Prestigious Award for Innovative Engineering
Owlstone Medical, a diagnostics company developing a breathalyzer for disease, has announced the team behind the Company’s unique Breath Biopsy® platform has been named the winner of the MacRobert Award 2018 by the Royal Academy of Engineering. Owlstone Medical’s Breath Biopsy platform, including the ReCIVA Breath Sampler, has opened up the potential for earlier diagnosis…
Read MoreBoston Scientific to Pay $202 Million for Cryterion Medical
Boston Scientific Corporation today announced a definitive agreement to acquire Cryterion Medical, Inc., a privately-held company developing a single-shot cryoablation platform for the treatment of atrial fibrillation (AF). The addition of this cryoballoon platform positions the company as the first to have both cryothermal and radiofrequency (RF) single-shot, balloon-based ablation therapies in its portfolio. Boston…
Read MoreFlorida Hospital First in State to Adopt BodyTom Elite, Samsung’s Updated CT Scanner
DANVERS, MA, June 7, 2018 – NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd., a leader in medical imaging technology, announced today that Florida Hospital in Orlando, Fl., added the BodyTom® Elite, the newly upgraded, portable, 32-slice computed tomography scanner, to their brachytherapy suite. The BodyTom Elite improves the patient experience, patient safety and workflow efficiency by…
Read MoreBrain Stimulation May Reduce Desire to Commit Sexual Assault
Stimulating the prefrontal cortex, the part of the brain responsible for controlling complex ideas and behaviors, can reduce a person’s intention to commit a violent act by more than 50 percent, according to research published in the Journal of Neuroscience from the University of Pennsylvania and Nanyang Technological University. What’s more, using such a minimally invasive technique, called transcranial direct-current…
Read MoreMassachusetts Biotech Sees Record Year for IPOs
It’s been a pretty good year for mergers and acquisitions in the biopharma industry, with Takeda Pharmaceutical buying Shire for $62.2 billion, and the year starting with Sanofi buying Bioverativfor $11.6 billion and then Ablynx for $4.8 billion. Celgene acquired Juno Therapeutics for $9 billion, shortly after buying Impact Biomedicines for $1.1 billion. But the landscape for initial public offerings (IPOs) has been excellent as well, particularly in Massachusetts, which has recorded 13 IPOs…
Read MoreMiMedx CEO and President Out Amid Corporate Turmoil
MiMedx, the Marietta biopharma company rocked by allegations of inflated earnings and improper sales practices, said Monday the company’s longtime chairman and CEO has resigned. Parker H. “Pete” Petit, a fixture in metro Atlanta’s business community, resigned both as CEO and chairman, though he will remain a member of the MiMedx board, the company said in…
Read More